The ypN0 rate was highly related to pCR-B (92.0%) and tumor subtype (81.6% for HER2-positive, 75.0% for TNBC, and 25.9% for luminal HER2-negative disease) (Table 1). This evidence concerns the gene ERBB2 and neoplasm.